MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and ...

Nutcracker Therapeutics will highlight its end-to-end microfluidic platform enabling rapid manufacturing of PCTs at leading ...

Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that ...

EPS, expectations were $0.03. Operator: Good morning, and welcome to Bausch + Lomb’s First Quarter 2025 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] Please note ...

CVS Health Corporation ( NYSE: CVS) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET David Joyner - President, Chief Executive Officer Tom Cowhey - Executive Vice President, Chief Financial ...

Outlines Disciplined Strategy to Position Nano Dimension as a Digital Manufacturing Leader Benefiting From the Global Trade and Production Realignment Details Post-Acquisition Playbook and Operational ...

On March 31, 2025, Phathom launched a celebrity partnership with Kenan Thompson as part of the GERD IS NO JOKE campaign, marking his first public discussion about living with GERD and finding relief ...

Two students from the Texas A&M Engineering Academy at Blinn-Brenham are reaching for the stars — or at least the moon — as part of a prestigious team selected as finalists in a NASA-sponsored ...

Between the expo hall, receptions and educational sessions, FA&M 2025 offered attendees an in-depth look at the latest in ...

Martinrea International Inc. (TSX : MRE), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added ...

Aimia Inc. will announce its first quarter 2024 financial results for the period ended March 31, 2025 on Tuesday, May 13, 2025. Aimia's financial results are expected to be released at approximately 7 ...